Bulletin board
Regulatory Updates

Part N – Schedule I Drugs

Section 11 (Sale of Schedule I Drugs Without a Prescription) of Part N - Schedule I Drugs of the regulatory bylaws has been updated to correct administrative errors and to delete unnecessary subsections. more..
 

EXEMPTION 56 - METHADONE

Subsection 56(1) Class Exemption expires on September 30, 2019. Exemption info MicroSCOPe article..
 

Epinephrine Ampoules are back on Schedule I

At the December 2018 meeting, Council decided not to extend the temporary bylaw that came into effect on August 27, 2018, which moved epinephrine ampoules from Schedule I to Schedule II for the treatment of anaphylaxis due to allergens. Therefore, effective December 31, 2018, epinephrine ampoules for anaphylaxis are no longer Schedule II and are back on Schedule I status...
 

Naloxone Unscheduled

Saskatchewan becomes the third province to move naloxone to unscheduled status more..
 

REGULATORY BYLAW REPEALED

Effective March 16, 2018, Part N, section 11(2) of the SCPP Regulatory Bylaws was repealed (linked document updated March 22) more..
 

MIFEGYMISO PRESCRIBING AND DISPENSING UPDATE

Please review the November 7, 2017, Health Canada updates to prescribing and dispensing information for Mifegymiso®  here ..
 

CQI BYLAWS APPROVED

The Minister of Health has approved the bylaws that set the Continuous Quality Improvement (CQI) program requirement, which will be met by COMPASS starting with the 2017-2018 permit year. The new bylaws can be found in Section 12 of Part I in the SCPP Regulatory Bylaws.  more ..
 

MINOXIDIL NOW UNSCHEDULED

Effective July 20, 2017, topical minoxidil, in concentrations of 5% or less, is now an unscheduled product and may be sold from any retail outlet (including online)  more ..
 
Events
Mar
28

Older Adults Conference 2020

March 28 in Saskatoon. Save the date. Registration coming soon poster   
 

Calendar View

SASKATCHEWAN COLLEGE OF PHARMACY PROFESSIONALS

Powered by in1touch